Treatment of allergic conjunctivitis with bepotastine besilate ophthalmic solution 1.5% [PDF]
Mark T Bergmann,1 Jon I Williams,2 Paul J Gomes3On behalf of the Bepotastine Besilate Ophthalmic Solutions Clinical Study Group 1Eye Care Associates of Greater Cincinnati, Inc., Cincinnati, OH, USA; 2Bausch + Lomb, Irvine, CA, USA; 3Ora, Inc., Andover ...
Bergmann MT, Williams JI, Gomes PJ
doaj +9 more sources
Background -Ocular allergy is a commonly encountered pathology in clinical practice, which often is under diagnosed and consequently undertreated.
A. Manekar, Sharayu Ashok Bhore
semanticscholar +3 more sources
Development of Analytical Method to Monitor Dissolution of Bepotastine Besilate Tablet [PDF]
Bepotastine Besilate is an anti-histaminic drug and it is marketed as tablet of strength 10mg. In this study an attempt is made to monitor the dissolution of Bepotastine Besilate tablet.
M. Damle, K. Pardeshi
semanticscholar +3 more sources
Development and Characterization of In Situ Ophthalmic Gel of Bepotastine Besilate [PDF]
The aim of the present work was development and characterization of in-situ Ophthalmic Gel of Bepotastine Besilate to overcome the drawbacks obtained by conventional eye drop. There are two independent variables were used i.e.
L. Garge, R. Saudagar
semanticscholar +3 more sources
Bepotastine besilate: A novel anti-histamine
Oral bepotastine is a nonsedative second-generation antihistamine with an action on other inflammatory mediators. It also acts as a mast cell stabilizer and leukotrienes inhibitor. Its distribution in the brain is very limited.
K. Godse, N. Kumari
semanticscholar +3 more sources
Novel Functional Aspect of Antihistamines: The Impact of Bepotastine Besilate on Substance P‐Induced Events [PDF]
Besides histamine, substance P (SP) has been demonstrated to play a crucial role in pruritic skin diseases. Although antihistamines are frequently used for pruritic skin diseases, little is known concerning the effect on an SP‐induced event such as mast cell degranulation and the upregulation of adhesion molecules or the nitric oxide (NO) synthesis in ...
Shun Kitaba +5 more
wiley +5 more sources
Comparative Efficacy of Bepotastine Besilate 1.5% Ophthalmic Solution Versus Olopatadine Hydrochloride 0.2% Ophthalmic Solution Evaluated by Patient Preference [PDF]
Craig F McCabe, Shannon E McCabeMcCabe Vision Center, Murfreesboro, TN, USABackground: The aim of this study was to compare patient-perceived relief of ocular itch, nasal symptoms, and eye drop comfort when allergic conjunctivitis was treated with ...
Shannon E McCabe
exaly +4 more sources
Critical appraisal of bepotastine in the treatment of ocular itching associated with allergic conjunctivitis [PDF]
Jeremy B Wingard, Francis S MahUPMC Eye Center, Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USAAbstract: Bepotastine besilate 1.5% solution is an H1-antihistamine recently approved by the Food and Drug ...
Jeremy B Wingard, Francis S Mah
doaj +4 more sources
Comparative evaluation of efficacy and safety of bepotastine besilate 1.5% ophthalmic solution versus olopatadine hydrochloride 0.1% ophthalmic solution in patients with vernal keratoconjunctivitis [PDF]
Background: Vernal keratoconjunctivitis (VKC) is a chronic, seasonally exacerbated, allergic ocular inflammation. It affect children and young adults and has male predominance.
Priyansh Gupta, S. Baishnab, P. Rewri
semanticscholar +2 more sources
Efficacy of Bepotastine versus Olopatadine Ophthalmic Solutions in Mild to Moderate Vernal Keratoconjunctivitis as a Sole Therapy [PDF]
Introduction: Vernal Keratoconjunctivitis (VKC) is a chronic, seasonally exacerbated allergic ocular inflammation of the conjunctiva. It affects predominantly the school going male population and is not so common.
Rahul Dara +5 more
doaj +2 more sources

